Cardlytics (CDLX) Asset Writedowns and Impairment (2017 - 2026)

Cardlytics (CDLX) has 10 years of Asset Writedowns and Impairment data on file, last reported at $335000.0 in Q1 2026.

• Quarterly Asset Writedowns and Impairment fell 47.9% year-over-year to $335000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.4 million (down 55.09% YoY) and the FY2025 annual result came in at $58.8 million, down 55.28% from the prior year.
• Asset Writedowns and Impairment retreated to $335000.0 in Q1 2026, from $58.8 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $452.3 million in Q4 2022 to a low of -$246000.0 in Q1 2023.
• A 5-year average of $48.0 million and a median of $990000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 171.1% — and 2024, when it soared 32074.82%.
• Tracing CDLX's Asset Writedowns and Impairment over 5 years: stood at $452.3 million in 2022, then slumped by 84.67% to $69.4 million in 2023, then surged by 89.71% to $131.6 million in 2024, then sank by 55.28% to $58.8 million in 2025, then tumbled by 99.43% to $335000.0 in 2026.
• The last three Asset Writedowns and Impairment figures came in at $335000.0 (Q1 2026), $58.8 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.